Moderna Inc.



Market open

 --Real time quotes

Aug 6, 2020, 12:37 p.m.





-1.67 -2.20%


Volume 6.97m

Real time quotes


Previous close

$ 75.80

$ 74.13


-1.67 -2.20%

Day low

Day high




52 week low

52 week high




Annual Financials for Moderna Inc.

Fiscal year is January-December. All values USD millions. 2016201720182019 5-year trend
Sales/Revenue -108.4M205.83M135.07M60.21M
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -15.11M20.54M24.86M31.02M
Depreciation -15.11M20.54M24.86M31.02M
Amortization of Intangibles -----
Gross Income -----
2016201720182019 5-year trend
SG&A Expense -317.05M454.64M579.07M574.91M
Research & Development -274.72M410.46M509.68M465.29M
Other SG&A -42.34M44.19M69.39M109.62M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense -(2.71M)(1.74M)4.93M(914,000)
Non-Operating Interest Income -11.31M15.24M27.02M38.53M
Equity in Affiliates (Pretax) -----
Interest Expense --132,0003.1M6.61M
Gross Interest Expense --132,0003.1M6.61M
Interest Capitalized -----
Pretax Income -(215.17M)(256M)(440.01M)(514.72M)
Income Tax -1.04M(80,000)(55.27M)(695,000)
Income Tax - Current Domestic -755,000(80,000)326,000505,000
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -288,000--(1.2M)
Income Tax - Deferred Foreign -----
Income Tax Credits ---55.6M-
Equity in Affiliates -----
Other After Tax Income (Expense) ---(4.13M)-
Consolidated Net Income -(216.21M)(255.92M)(388.86M)(514.02M)
Minority Interest Expense -----
Net Income -(216.21M)(255.92M)(388.86M)(514.02M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(216.21M)(255.92M)(388.86M)(514.02M)
Preferred Dividends -14.1M13.93M13M-
Net Income Available to Common -(230.31M)(269.84M)(401.86M)(514.02M)
EPS (Basic) -(0.69)(1.92)(4.95)(1.55)
Basic Shares Outstanding -332.89M140.6M81.11M330.8M
EPS (Diluted) -(0.69)(1.92)(4.95)(1.55)
Diluted Shares Outstanding -332.89M140.6M81.11M330.8M
EBITDA -(208.66M)(248.82M)(444M)(514.7M)
Link to MarketWatch's Slice.